While Vicarious Surgical Inc has underperformed by -1.23%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RBOT fell by -84.73%, with highs and lows ranging from $2.47 to $0.20, whereas the simple moving average fell by -57.53% in the last 200 days.
On March 04, 2022, Piper Sandler Downgraded Vicarious Surgical Inc (NYSE: RBOT) to Neutral. A report published by Credit Suisse on January 07, 2022, Initiated its previous ‘Outperform’ rating for RBOT. Cowen also rated RBOT shares as ‘Outperform’, setting a target price of $15 on the company’s shares in an initiating report dated December 07, 2021. Canaccord Genuity Initiated an Buy rating on November 05, 2021, and assigned a price target of $15. BTIG Research initiated its ‘Buy’ rating for RBOT, as published in its report on October 18, 2021. Piper Sandler’s report from October 07, 2021 suggests a price prediction of $16 for RBOT shares, giving the stock a ‘Overweight’ rating.
Analysis of Vicarious Surgical Inc (RBOT)
One of the most important indicators of Vicarious Surgical Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -68.01% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 13.87, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and RBOT is recording 775.50K average volume. On a monthly basis, the volatility of the stock is set at 14.95%, whereas on a weekly basis, it is put at 14.32%, with a loss of -0.03% over the past seven days. Furthermore, long-term investors anticipate a median target price of $1.03, showing growth from the present price of $0.35, which can serve as yet another indication of whether RBOT is worth investing in or should be passed over.
How Do You Analyze Vicarious Surgical Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 59.69%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 19.29% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RBOT shares are owned by institutional investors to the tune of 19.29% at present.
